A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma (PICASSO)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

ZIOPHARM

ClinicalTrials.gov Identifier:

NCT00718484

First received: July 16, 2008

Last updated: July 17, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2012
Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)